Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 3721 AL 3735

Microglia-Mediated Inflammation and Neurodegenerative Disease

Xu L, He D, Bai Y.

Mol Neurobiol. 2016 Dec;53(10):6709-6715. doi: 10.1007/s12035-015-9593-4. Epub 2015 Dec 10.

Double-Orifice Tricuspid Valve: A Case Report and Literature Review

Dabirian M, Nabati M, Jalalian R, Shokri M.

Echocardiography. 2016 Mar;33(3):479-83. doi: 10.1111/echo.13127. Epub 2015 Dec 13.

Toward affordable falls prevention in Parkinson's disease

de Vries NM, Nonnekes J, Bloem BR.

Mov Disord. 2016 Jan;31(1):3-6. doi: 10.1002/mds.26474. Epub 2015 Dec 11.

The effect of the rehabilitation program on balance, gait, physical performance and trunk rotation in Parkinson's disease

Stożek J, Rudzińska M, Pustułka-Piwnik U, Szczudlik A.

Aging Clin Exp Res. 2016 Dec;28(6):1169-1177. doi: 10.1007/s40520-015-0506-1. Epub 2015 Dec 10.

Peripheral neuropathy and levodopa therapy in Parkinson disease: novel insights

Kimber T, Antonini A.

Eur J Neurol. 2016 Mar;23(3):435-6. doi: 10.1111/ene.12912. Epub 2015 Dec 14.

Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment

Gasca-Salas C, Clavero P, García-García D, Obeso JA, Rodríguez-Oroz MC.

Hum Brain Mapp. 2016 Mar;37(3):968-77. doi: 10.1002/hbm.23080. Epub 2015 Dec 14.

The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy

McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, Perl DP, Stein TD, Vonsattel JP, Stewart W, Tripodis Y, Crary JF, Bieniek KF, Dams-O'Connor K, Alvarez VE, Gordon WA; TBI/CTE group.

Acta Neuropathol. 2016 Jan;131(1):75-86. doi: 10.1007/s00401-015-1515-z. Epub 2015 Dec 14.

A process evaluation of a home-based occupational therapy intervention for Parkinson's patients and their caregivers performed alongside a randomized controlled trial

Sturkenboom IH, Nijhuis-van der Sanden MW, Graff MJ.

Clin Rehabil. 2016 Dec;30(12):1186-1199. doi: 10.1177/0269215515622038. Epub 2015 Dec 16.

The construct validity of the Dutch version of the activity card sort

Poerbodipoero SJ, Sturkenboom IH, van Hartingsveldt MJ, Nijhuis-van der Sanden MW, Graff MJ.

Disabil Rehabil. 2016 Sep;38(19):1943-51. doi: 10.3109/09638288.2015.1107779. Epub 2015 Dec 16.

Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease

Infante J, Prieto C, Sierra M, Sánchez-Juan P, González-Aramburu I, Sánchez-Quintana C, Berciano J, Combarros O, Sainz J.

Neurobiol Aging. 2016 Feb;38:214.e1-214.e5. doi: 10.1016/j.neurobiolaging.2015.10.026. Epub 2015 Oct 31.

Effects of coffee/caffeine on brain health and disease: What should I tell my patients?

Nehlig A.

Pract Neurol. 2016 Apr;16(2):89-95. doi: 10.1136/practneurol-2015-001162. Epub 2015 Dec 16.

Are factors related to dual-task performance in people with Parkinson's disease dependent on the type of dual task?

Strouwen C, Molenaar EA, Keus SH, Münks L, Heremans E, Vandenberghe W, Bloem BR, Nieuwboer A.

Parkinsonism Relat Disord. 2016 Feb;23:23-30. doi: 10.1016/j.parkreldis.2015.11.020. Epub 2015 Nov 27.

Novel Therapeutic Targets and Drug Candidates for Modifying Disease Progression in Adrenoleukodystrophy

Pujol A.

Endocr Dev. 2016;30:147-60. doi: 10.1159/000439340. Epub 2015 Dec 10.

Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial

Ponce FA, Asaad WF, Foote KD, Anderson WS, Rees Cosgrove G, Baltuch GH, Beasley K, Reymers DE, Oh ES, Targum SD, Smith GS, Lyketsos CG, Lozano AM; ADvance Research Group.

J Neurosurg. 2016 Jul;125(1):75-84. doi: 10.3171/2015.6.JNS15716. Epub 2015 Dec 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias